Literature DB >> 24907210

Squamous cell carcinoma of external auditory canal lacking epidermal growth factor receptor protein overexpression, in an elderly Omani with oculocutaneous albinism treated with palliative radiotherapy.

Muhammad Furrukh1, Taha Mufti1, Rana Shoaib Hamid2, Asim Qureshi3.   

Abstract

We report a case of squamous cell carcinoma of external auditory canal in an Omani man with oculocutaneous albinism. The disease mimicked inflammatory process revealing positive cultures for various microorganisms during the course of his illness. He was eventually biopsied to rule out atypical infective process or presence of malignancy. He was staged as T4N0M0 and treated with radical doses of palliative radiation therapy which was very well tolerated and resulted in a complete resolution of disease clinically and a major soft tissue response on radiological imaging. Another unique finding was the absence of epidermal growth factor receptor (EGFR) protein overexpression in the tumour specimen. More than 90% of mucosal squamous cell carcinoma (SCC) involving the head and neck region overexpress the EGFR protein in normal skin patients. SCC is the predominant cutaneous malignancy in albinos, and the presence of EGFR protein overexpression in cutaneous SCC is believed to be 56-58% in normal skin patients. The scientific literature is scarce on reporting incidence of EGFR overexpression in either cutaneous or mucosal SCC in albinos, and it remains to be defined whether being albino is the cause for its absence. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24907210      PMCID: PMC4054485          DOI: 10.1136/bcr-2013-203226

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.

Authors:  Larissa Sweeny; Nichole R Dean; J Scott Magnuson; William R Carroll; Emily E Helman; Stephen O Hyde; Renee L Desmond; Eben L Rosenthal
Journal:  Head Neck       Date:  2011-07-07       Impact factor: 3.147

2.  Cancer statistics, 2001.

Authors:  R T Greenlee; M B Hill-Harmon; T Murray; M Thun
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

Review 3.  Epidermal growth factor receptor biology in head and neck cancer.

Authors:  Shailaja Kalyankrishna; Jennifer R Grandis
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

4.  Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Authors:  J Rubin Grandis; M F Melhem; W E Gooding; R Day; V A Holst; M M Wagener; S D Drenning; D J Tweardy
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

5.  Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Authors:  Jan B Vermorken; Ricard Mesia; Fernando Rivera; Eva Remenar; Andrzej Kawecki; Sylvie Rottey; Jozsef Erfan; Dmytro Zabolotnyy; Heinz-Roland Kienzer; Didier Cupissol; Frederic Peyrade; Marco Benasso; Ihor Vynnychenko; Dominique De Raucourt; Carsten Bokemeyer; Armin Schueler; Nadia Amellal; Ricardo Hitt
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

6.  Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.

Authors:  Shen Keren; Zhang Shoude; Zhao Lu; Yang Beibei
Journal:  Tumour Biol       Date:  2014-03

7.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K Kian Ang
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

Review 8.  Oculocutaneous albinism.

Authors:  Karen Grønskov; Jakob Ek; Karen Brondum-Nielsen
Journal:  Orphanet J Rare Dis       Date:  2007-11-02       Impact factor: 4.123

  8 in total
  1 in total

1.  Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.

Authors:  Xue-Ling Mei; Shan Zhong
Journal:  Chin Med J (Engl)       Date:  2019-02       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.